Structure, heterogeneity and developability assessment of therapeutic antibodies

  • Yingda Xu
    Protein Analytics, Adimab, Lebanon, NH, USA
  • Dongdong Wang
    Analytical Department, Bioanalytix, Inc., Cambridge, MA, USA
  • Bruce Mason
    Product Characterization, Alexion Pharmaceuticals, Inc., New Haven, CT, USA
  • Tony Rossomando
    Product Characterization, Alexion Pharmaceuticals, Inc., New Haven, CT, USA
  • Ning Li
    Analytical Chemistry, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
  • Dingjiang Liu
    Formulation Development, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
  • Jason K Cheung
    Pharmaceutical Sciences, MRL, Merck & Co., Inc., Kenilworth, NJ, USA
  • Wei Xu
    Analytical Method Development, MRL, Merck & Co., Inc., Kenilworth, NJ, USA
  • Smita Raghava
    Sterile Formulation Sciences, MRL, Merck & Co., Inc., Kenilworth, NJ, USA
  • Amit Katiyar
    Analytical Development, Bristol-Myers Squibb, Pennington, NJ, USA
  • Christine Nowak
    Product Characterization, Alexion Pharmaceuticals, Inc., New Haven, CT, USA
  • Tao Xiang
    Manufacturing Sciences, Abbvie Bioresearch Center, Worcester, MA, USA
  • Diane D. Dong
    Manufacturing Sciences, Abbvie Bioresearch Center, Worcester, MA, USA
  • Joanne Sun
    Product development, Innovent Biologics, Suzhou Industrial Park, China
  • Alain Beck
    Analytical chemistry, NBEs, Center d’immunologie Pierre Fabre, St Julien-en-Genevois Cedex, France
  • Hongcheng Liu
    Product Characterization, Alexion Pharmaceuticals, Inc., New Haven, CT, USA

収録刊行物

  • mAbs

    mAbs 11 (2), 239-264, 2018-12-17

    Informa UK Limited

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ